BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gorenjak M, Zupin M, Jezernik G, Skok P, Potočnik U. Omics data integration identifies ELOVL7 and MMD gene regions as novel loci for adalimumab response in patients with Crohn's disease. Sci Rep 2021;11:5449. [PMID: 33750834 DOI: 10.1038/s41598-021-84909-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gorenjak M, Jezernik G, Krušič M, Skok P, Potočnik U. Identification of Novel Loci Involved in Adalimumab Response in Crohn’s Disease Patients Using Integration of Genome Profiling and Isoform-Level Immune-Cell Deconvoluted Transcriptome Profiling of Colon Tissue. Pharmaceutics 2022;14:1893. [DOI: 10.3390/pharmaceutics14091893] [Reference Citation Analysis]
2 Zhou J, Xu Z, Jin Y, Zhang X, Gu Y, Ma J, Wen X, Lin J, Zhang T, Qian J. Whole-Genome DNA Methylation Sequencing Reveals Epigenetic Changes in Myelodysplastic Syndromes. Front Oncol 2022;12:897898. [DOI: 10.3389/fonc.2022.897898] [Reference Citation Analysis]
3 Kwak MS, Cha JM, Jeon JW, Yoon JY, Park SB. Uncovering Novel Pre-Treatment Molecular Biomarkers for Anti-TNF Therapeutic Response in Patients with Crohn’s Disease. JFB 2022;13:36. [DOI: 10.3390/jfb13020036] [Reference Citation Analysis]
4 Skok K, Gradišnik L, Čelešnik H, Milojević M, Potočnik U, Jezernik G, Gorenjak M, Sobočan M, Takač I, Kavalar R, Maver U. MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines. Cells 2021;11:117. [PMID: 35011679 DOI: 10.3390/cells11010117] [Reference Citation Analysis]
5 Krsteski J, Gorenjak M, But I, Pakiž M, Potočnik U. Dysregulation of Synaptic Signaling Genes Is Involved in Biology of Uterine Leiomyoma. Genes (Basel) 2021;12:1179. [PMID: 34440356 DOI: 10.3390/genes12081179] [Reference Citation Analysis]